| Product NDC: | 52533-074 |
| Proprietary Name: | Fentanyl Citrate |
| Non Proprietary Name: | Fentanyl Citrate |
| Active Ingredient(s): | 50 ug/mL & nbsp; Fentanyl Citrate |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 52533-074 |
| Labeler Name: | Cantrell Drug Company |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | |
| Marketing Category: | UNAPPROVED DRUG OTHER |
| Start Marketing Date: | 20111020 |
| Package NDC: | 52533-074-16 |
| Package Description: | 2 mL in 1 SYRINGE (52533-074-16) |
| NDC Code | 52533-074-16 |
| Proprietary Name | Fentanyl Citrate |
| Package Description | 2 mL in 1 SYRINGE (52533-074-16) |
| Product NDC | 52533-074 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Fentanyl Citrate |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS |
| Start Marketing Date | 20111020 |
| Marketing Category Name | UNAPPROVED DRUG OTHER |
| Labeler Name | Cantrell Drug Company |
| Substance Name | FENTANYL CITRATE |
| Strength Number | 50 |
| Strength Unit | ug/mL |
| Pharmaceutical Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |